Esperite has taken distance from the operative part of its activities and focus its effort on turning itself in an investment company with a focus on Health Care and High-Tech Service.
Consequently, Esperite becomes an established investment group which focuses on the health care segment and the biotechnology activities. With more than 20 years of experience, Esperite operates now a light and efficient structure dedicated to growth and active development.
Esperite capitalise on its experience over the last 20 years of existence. Above all, Esperite is now an investment company with a strict focus on short to mid-term profitability and value creation for its shareholders
Esperite doesn’t want to invest in fundamental research. Furthermore, its goals are realistic, based on proven technologies, with a concrete background and a high potential to access the commercial markets
Esperite believes in short term return on investment and has a focus on translational medicine which provides direct access to the patients direct access to the latest technologies
Esperite wants to consider any opportunity as a challenge for the benefit of its shareholders. As a result, Esperite wants to create a network of reputable partners and establish partnership with a selection of them